Building Competency in Diabetes Education THE ESSENTIALS

BASAL-BOLUS INSULIN THERAPY | 12-105

14. Shalitin S, Phillip M. Hypoglycemia in type 1 diabetes: A still unresolved problem in the era of insulin analogs and pump therapy. Diabetes Care 2008;31:S121-S124.

15. Yale JF, Paty B, Senior PA. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada: Hypoglycemia. Can J Diabetes 2018;42(Suppl 1):S104-S108. 16. Bolli G. How to ameliorate the problem of hypoglycemia in intensive as well as non intensive treatment of type 1 diabetes. Diabetes Care 1999;22(Suppl 2):B43-B52. 17. Hirsch IB. Insulin analogues. N Engl J Med 2005;352:174-83. 18. DeVries JH, Nattrass M, Pieber TR. Refining basal insulin therapy: What have we learned in the age of analogues? Diabetes Metab Res Rev 2007;23:441-54. 19. Chase HP, Lockspeiser T, Peery B, et al. The impact of the Diabetes Control and Complications Trial and Humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care 2001;24:430-4. 20. Yale JF, Begg I, Gerstein H, et al. 2001 Canadian Diabetes Association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Can J Diabetes 2002;26:22-35. 21. Nathan DM, Cleary PA, Backlund JY, et al; Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53. 22. Mudaliar S, Edelman SV. Insulin therapy in type 2 diabetes. Endocrinol Metab Clin North Am 2001;30:935-82. 23. Kramer C, Zinman B, Retnakaran R. Short-term intensive insulin therapy in type 2 diabetes mellitus: A systematic review and meta-analysis. Lancet Diabetes Endocrinol 2013;1:28-34. 24. Shichiri M, Kishikawa H, Ohkubo Y, et al. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000;23(Suppl 2):B21-B29. 25. The Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995;18:361-76. 26. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-9. 27. New DCCT Data: HbA1c Matters Today, Tomorrow, and 20 Years On. Medscape.